Role of Targeted Sequencing in Routine Diagnostics of Spitz Melanocytic Neoplasms—An Analysis of 70 Cases
Journal of Cutaneous Pathology · 2025-02 · 52 (2) · 141-153
DOI: 10.1111/cup.14750 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, online erschienen am 07.11.2024. Verfasst von Daja Šekoranja und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Nevus, Epithelioid and Spindle Cell, Skin Neoplasms, Melanoma, Mutation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije.
Abstract (Originalsprache)
Background
There is growing evidence that the Spitz group of melanocytic neoplasms should be restricted to those harboring kinase receptor fusions and HRAS mutations/11p15 amplification. The presence of genomic alterations characteristic of conventional melanomas ( BRAF and NRAS mutations) precludes a diagnosis of a Spitz neoplasm. It is often challenging to distinguish Spitz neoplasms from conventional melanomas with spitzoid morphology on histopathological grounds alone.
Methods
We report a series of 70 consecutive melanocytic tumors in which targeted sequencing was indicated to distinguish Spitz from spitzoid neoplasms and to classify Spitz neoplasms along the biological spectrum.
Results
Final diagnoses incorporating molecular results included 12 conventional melanomas (nine of which with NRAS mutations), five Spitz melanomas, 35 atypical Spitz tumors, eight Spitz nevi, three melanocytic tumors with a MAP2K1 mutation, and seven desmoplastic Spitz nevi/tumors. There were significant discrepancies between initial diagnoses and final diagnoses after incorporating molecular results in 24 (34%) cases, including nine conventional melanomas favored to be Spitz neoplasms and nine Spitz neoplasms favored to be conventional melanomas.
Conclusions
It is often not possible to reliably distinguish Spitz neoplasms from spitzoid melanocytic tumors without identifying their driver genomic alterations. Applying next‐generation sequencing in diagnostically problematic tumors improves diagnostic accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pathology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- Department of Dermatopathology, St John's Institute of Dermatology, London, UK.
ORCID-Profile: Daja Šekoranja, Andrej Zupan, Alenka Matjašič, Emanuela Boštjančič, Jože Pižem
Förderung
- Javna agencija za znanstvenoraziskovalno in inovacijsko dejavnost Republike Slovenije
Zitieren
APA
Šekoranja, D., Zupan, A., Matjašič, A., Boštjančič, E., Calonje, E., & Pižem, J. (2025). Role of Targeted Sequencing in Routine Diagnostics of Spitz Melanocytic Neoplasms—An Analysis of 70 Cases. Journal of Cutaneous Pathology, 52(2), 141-153. https://doi.org/10.1111/cup.14750
Vancouver
Šekoranja D, Zupan A, Matjašič A, Boštjančič E, Calonje E, Pižem J. Role of Targeted Sequencing in Routine Diagnostics of Spitz Melanocytic Neoplasms—An Analysis of 70 Cases. Journal of Cutaneous Pathology. 2025;52(2):141-153. doi:10.1111/cup.14750
BibTeX
@article{ekoranja2025,
author = {Šekoranja, Daja and Zupan, Andrej and Matjašič, Alenka and Boštjančič, Emanuela and Calonje, Eduardo and Pižem, Jože},
title = {Role of Targeted Sequencing in Routine Diagnostics of Spitz Melanocytic Neoplasms—An Analysis of 70 Cases},
journal = {Journal of Cutaneous Pathology},
year = {2025},
volume = {52},
number = {2},
pages = {141--153},
doi = {10.1111/cup.14750}
}
EUVIMED